Abiopharma

🔍 Wenger E Philip (Executive)

Company: FULTON FINANCIAL CORP (FULT)

Report Date: 2026-06-01

Detailed Transactions and Holdings:

• Acquired 5,117 shares of $2.50 par value Common Stock (Direct)
  Date: 2026-06-01 | Code: M | equity_swap_involved: false | shares_owned_after: 583,918.88 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of $2.50 par value Common Stock (Direct)
  Date: 2026-06-01 | Code: H | nature_of_ownership: By Children | shares_owned_after: 459.67
• Holds 0 shares of $2.50 par value Common Stock (Direct)
  Date: 2026-06-01 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 80,477.00
• Sold 5,117 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-01 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Acquired 4,222 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-01 | Code: A | equity_swap_involved: false | shares_owned_after: 4,222.00 | transaction_form_type: 4 | Footnotes: F2, F4, F4

Footnotes:

• F1: Includes 120,996.5261 shares held jointly with spouse.
• F2: Each restricted stock unit represents a contingent right to receive one share of Fulton Financial Corporation common stock, $2.50 par value per share.
• F3: Represents 4,928 restricted stock units granted to the reporting person on June 1, 2025, together with 188.838338 accumulated dividend equivalents, for which the forfeiture restrictions lapsed on June 1, 2026. The common stock into which the restricted stock units were converted is reported in Table I of this Form 4.
• F4: The restricted stocks units, together with accumulated dividend equivalents, will convert to common stock on the first anniversary of the date of the grant or, at the election of the reporting person, in up to three equal annual installments beginning in January of the year following the year in which the reporting person retires or separates from the Fulton Financial Corporation Board of Directors.
• F5: Forfeiture restrictions lapse on the restricted stock units on the first anniversary of the date of grant, or earlier in accordance with the Fulton Financial Corporation Amended and Restated 2023 Director Equity Plan.